AAAAI Podcast: Conversations from the World of Allergy

Join us as Kelly Stone, MD, PhD, FAAAAI, explains the evolution of the U.S. Food and Drug Administration and its central role in ensuring the safety and efficacy of therapeutics in the United States. We discuss the modern drug approval process from preclinical development through clinical trials and post-marketing surveillance  and explore what makes this pathway different for biologics and biosim...

Join us as Derek Chu, MD, PhD, explores the paradigm shift in treating atopic dermatitis as a systemic, immune-driven disease rather than a localized skin condition. We discuss the updates to the practice parameters including practical guidance on integrating of novel topicals, biologics, and JAK inhibitors into our treatment as well as the upcoming practice parameters on chronic spontaneous urtic...

Join us as Monica Kraft, MD, FAAAAI, provides an evidence-based framework for managing allergic conditions during pregnancy, focusing on the safety of commonly used medications, from inhaled corticosteroids and antihistamines to biologics. We address the risks of undertreated asthma and explore the latest recommendations for penicillin allergy delabeling to optimize maternal-fetal outcomes. The di...

In this episode, Christine Cho, MD, FAAAAI, discusses analyzing medical errors within the allergy clinic, from incorrect immunotherapy dosing to the systemic risks of penicillin mislabeling. Dr. Cho explains how shifting from a culture of blame to a "just culture" allows practices to transform "near misses" into learning opportunities that create more robust, reliable systems.

In honor of Food Allergy Awareness Week, we’re stepping out of the clinic and into the heat of the kitchen. Chef Ming Tsai shares an insider’s look at restaurant safety protocols, food allergy legislation and practical strategies physicians need to help patients with food allergies navigate the world with confidence. Find out more about food allergies. 

In this episode, we discuss the remarkable evolution of allergy and immunology through the lens of a career spanning six decades. Past AAAAI President Phil Lieberman, MD, FAAAAI, explores the pivotal scientific breakthroughs in the field starting with the discovery of IgE as he started in practice and taking us through target therapy has changed the lives of his patients. Dr. Lieberman offers us b...

Climate change is reshaping the landscape of allergy and immunology in ways that directly affect human health. In this episode, Jeffrey G. Demain, MD, FAAAAI, discusses how rising temperatures, shifting weather patterns and increased carbon dioxide levels are intensifying allergic diseases and altering immune responses worldwide.

AAAAI President Carla Davis, MD, FAAAAI, discusses her journey in allergy / immunology including key mentors and the initiatives in education, research and advocacy that she will be advancing over the next year. Learn how you can access education tailored to your interests through AAAAI Ignite and advocate for your patients through AAAAI Advocate. AAAAI Advocate

Alpha-gal syndrome has transformed our understanding of food allergy, linking tick bites to delayed anaphylaxis to mammalian meats. In this episode, we explore the epidemiology, immunologic mechanisms, diagnosis and management of alpha-gal syndrome with expert Scott Commins, MD, FAAAAI. Join us for practical clinical pearls and emerging insights into this unique disease. Continuing Medical Educati...

GLP-1 agonists have been blockbuster medications in diabetes and obesity but they may also have a surprising role in the treatment of asthma. Join the conversation as Katherine Cahill, MD, FAAAAI, discusses how GLP-1 agonists may improve asthma control and reduce airway inflammation. Find out more about asthma. 

Vaccines are a cornerstone of public health, training the immune system to prevent infectious diseases, especially in our most vulnerable patients. In this episode, John Kelso, MD, FAAAAI, reviews recent vaccine developments, including the importance of measles vaccination amid ongoing outbreaks, updates to vaccination schedules, considerations when using vaccines with biologics and evaluation of...

Improving access to penicillin allergy evaluation for millions of older patients would lead to better antibiotic treatment, decreased surgical site infections and fewer cases of C. diff. The Penicillin Allergy Verification and Evaluation Act has the potential to do just this. Priya Bansal, MD, FAAAAI, and Allison Ramsey, MD, FAAAAI, share their valuable insight into the Act and how we can make adv...

Julie Wang, MD, FAAAAI, shares highlights of the upcoming AAAAI Annual Meeting taking place in Philadelphia, Pennsylvania from February 27 to March 2. Listen in to hear what is in store this year as well as highlights such as the symposium on Philadelphia’s vaccine legacy as well as use of Artificial Intelligence and the new Practice Management Course. Visit the AAAAI Annual Meeting website.

As immunosuppressive therapies for cancer and autoimmune disease become more common, secondary immune deficiency is increasingly encountered in clinical practice. In this episode, Sara Barmettler, MD, FAAAAI, discusses the causes, diagnosis and management of secondary immune deficiency to help allergy and immunology physicians care for these patients effectively.

Join hereditary angioedema expert Aleena Banerji, MD, FAAAAI, for a discussion about the diagnosis and management of hereditary angioedema, focusing on treatment developments that have dramatically improved the care of patients with HAE. Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s )™ Fin...

Diagnosing Food Protein Induced Enterocolitis Syndrome (FPIES) can be challenging and once diagnosed, there are few options for treatment other than strict avoidance and waiting for resolution. Sara Anvari, MD, MSc, FAAAAI, discusses the presentation and pathophysiology of FPIES and how treatment options beyond avoidance are evolving. Continuing Medical Education credit is available with this epis...

How do families know when to give epinephrine and when to go to the ER? How long do we need to observe after an episode of anaphylaxis and who is at risk for recurrent symptoms? We discuss these important questions and more with Tim Dribin, MD, a pediatric emergency medicine physician, who is working to optimize emergency department care for patients with anaphylaxis. Learn more about anaphylaxis.

From now until December 31, 2025, AAAAI Fellows (those who have achieved the FAAAAI credential) and full members will select the next Board of Directors, including the next Secretary-Treasurer who will eventually ascend to become AAAAI President. Secretary-Treasurer candidates Stuart L. Abramson, MD, PhD, AE-C, FAAAAI, and Mariana C. Castells, MD, PhD, FAAAAI, offer their perspective on a series o...

Advising our families with food allergies as they navigate kids in school, holidays, introduction of foods in siblings, etc., can be challenging. Michael Pistiner, MD, MMSc, joins us to talk about resources we can use to help families introduce new foods and work with schools to help advocate for our patients. He also discusses his food allergy buddy program that allows older kids with food allerg...

Latex Allergy has become much less common over the past two decades thanks to widespread changes in healthcare practices but still remains essential to recognize when present. Jay Slater, MD, discusses the history of latex allergy as well as how to recognize and test for this in our patients. Find out more about latex allergy. 

Drug allergy expert David Khan, MD, FAAAAI, discusses the importance of evaluating patients with reported penicillin allergy and how allergists can partner with other healthcare providers to make sure all the patients with this label are evaluated.  Penicillin Allergy Toolbox

Urticaria expert Sarbjit (Romi) Saini, MD, FAAAAI, discusses new treatments for chronic urticaria, particularly BTK inhibitors. We discuss the recent trials with these medications, including efficacy and safety, as well as other medications on the horizon. Listen to our other podcast episodes. 

Many of us are seeing increasing numbers of patients asking us if they might have a mast cell disorder. How do we diagnose this and what clues will help us know whether or not to pursue this? Join Onyinye Iweala, MD, PhD, FAAAAI, as we discuss Mast Cell Activation Syndrome and how to better understand this confusing disorder.  The Mast Cell Disease Society Inc.

AAAAI President Frank Virant, MD, FAAAAI, discusses his career and how the field of allergy/immunology has changed over time. We also chatted about how his presidential initiatives are designed to help patients and allergists, including increasing the visibility of allergy as a specialty, creating living practice parameters and increasing the pipeline into the field.  

Join us as we discuss the work of three amazing scientists and the impact NIH support has had on their work. Leonard Bacharier’s, MD, FAAAAI, work has contributed to improving asthma guidelines in the preschool age group. The work of Corinne Keet, MD, MS, PhD, and Elizabeth Matsui, MD, MHS, FAAAAI, has been instrumental in improving our understanding of the effect of environmental exposures and th...